Continue to site >
Trending ETFs

Name

As of 05/28/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$15.94

$2.79 M

0.85%

$0.14

0.45%

Vitals

YTD Return

-5.3%

1 yr return

-5.6%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$2.79 M

Holdings in Top 10

21.3%

52 WEEK LOW AND HIGH

$16.0
$13.37
$18.52

Expenses

OPERATING FEES

Expense Ratio 0.45%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

As of 05/28/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$15.94

$2.79 M

0.85%

$0.14

0.45%

WDNA - Profile

Distributions

  • YTD Total Return -5.3%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.8%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    WisdomTree BioRevolution Fund
  • Fund Family Name
    WisdomTree Trust
  • Inception Date
    Jun 03, 2021
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Marlene Walker-Smith

Fund Description

The Fund employs a “passive management” – or indexing – investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole.

WisdomTree, Inc., the Index Provider and parent company of the Fund’s investment adviser, WisdomTree Asset Management, Inc. (“WisdomTree Asset Management” or the “Adviser”), designed the Index to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The Index constituents are determined by an Index committee that looks at companies focusing on: the application of genetic technologies to prevent and treat disease; the applications of human genetic technologies to new classes of consumer products personalized for each individual; the transformation of agriculture, aquaculture, and food production, creating healthier and more sustainable models for feeding the growing global population; biological re-engineering used to produce an increasing percentage of the physical inputs needed for manufacturing; and/or DNA as a storage solution (collectively, “BioRevolution Activities”).

To be eligible for inclusion in the Index, a company must meet the following criteria as of the Index screening date: (i) derive at least 50% of its revenue from BioRevolution Activities; (ii) have a market capitalization of at least $300 million; and (iii) have a median daily dollar volume of at least $1 million for each of the preceding three months.

The Index is a modified equally weighted index that is reconstituted and rebalanced semi-annually. The Index Provider currently uses the Global Industry Classification Standard (GICS®), a widely recognized industry classification methodology developed by MSCI, Inc. and Standard & Poor’s Financial Services LLC, to assign companies to a given sector or industry and identify the sectors represented in the Index. The sectors represented in the Index, as well as the extent of such representation, are expected to vary over time. A sector typically is comprised of multiple industries. For example, the Energy Sector is comprised of, among others, the Energy Equipment and Services Industry and the Oil, Gas and Consumable Fuels Industry. As of September 30, 2023, companies assigned to the Health Care Sector comprised a significant portion (i.e., approximately 15% or more of the total weighting) of the Index; however, the Index’s sector exposure may change from time to time.

To the extent the Index concentrates (i.e., holds more than 25% of its total assets) in the securities of companies assigned to a particular industry or group of industries, the Fund will concentrate its investments in such industry to approximately the same extent as the Index.

As of September 30, 2023, the equity securities of companies domiciled in or otherwise tied (e.g., a company’s principal place of business is maintained in that region or country) to each of the United States and Europe comprised a significant portion (i.e., approximately 15% or more of the total weighting) of the Index, although the Index’s geographic exposure may change from time to time.

Read More

WDNA - Performance

Return Ranking - Trailing

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
YTD -5.3% -25.6% 23.4% 98.88%
1 Yr -5.6% -30.0% 21.8% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
2023 -2.9% -53.9% 11.7% N/A
2022 -26.6% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
YTD -5.3% -41.2% 23.4% 98.88%
1 Yr -5.6% -30.0% 28.3% N/A
3 Yr N/A* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Total Return Ranking - Calendar

Period WDNA Return Category Return Low Category Return High Rank in Category (%)
2023 -2.1% -53.9% 11.7% N/A
2022 -26.3% -22.3% 18.5% N/A
2021 N/A -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

WDNA - Holdings

Concentration Analysis

WDNA Category Low Category High WDNA % Rank
Net Assets 2.79 M 732 K 46.2 B 94.54%
Number of Holdings 94 21 473 25.13%
Net Assets in Top 10 574 K 2.18 K 21.6 B 94.76%
Weighting of Top 10 21.27% 12.3% 80.8% 95.81%

Top 10 Holdings

  1. State Street Navigator Securities Lending Government Money Market Portfolio 3.77%
  2. Twist Bioscience Corp 3.29%
  3. Bridgebio Pharma Inc 2.35%
  4. Blueprint Medicines Corp 2.19%
  5. Iovance Biotherapeutics Inc 1.96%
  6. Editas Medicine Inc 1.60%
  7. Amicus Therapeutics Inc 1.57%
  8. Ginkgo Bioworks Holdings Inc 1.54%
  9. Fate Therapeutics Inc 1.52%
  10. Eli Lilly Co 1.49%

Asset Allocation

Weighting Return Low Return High WDNA % Rank
Stocks
99.81% 85.37% 106.13% 14.14%
Cash
3.77% -0.10% 9.01% 90.05%
Preferred Stocks
0.00% 0.00% 7.86% 57.07%
Other
0.00% -22.99% 3.38% 58.64%
Convertible Bonds
0.00% 0.00% 0.37% 57.07%
Bonds
0.00% 0.00% 12.39% 56.54%

Stock Sector Breakdown

Weighting Return Low Return High WDNA % Rank
Utilities
0.00% 0.00% 0.00% 54.97%
Technology
0.00% 0.00% 22.69% 58.64%
Real Estate
0.00% 0.00% 7.13% 58.12%
Industrials
0.00% 0.00% 7.02% 58.12%
Healthcare
0.00% 59.26% 100.00% 98.43%
Financial Services
0.00% 0.00% 1.85% 68.59%
Energy
0.00% 0.00% 0.00% 54.97%
Communication Services
0.00% 0.00% 9.11% 57.59%
Consumer Defense
0.00% 0.00% 25.73% 1.57%
Consumer Cyclical
0.00% 0.00% 14.20% 57.07%
Basic Materials
0.00% 0.00% 14.83% 0.52%

Stock Geographic Breakdown

Weighting Return Low Return High WDNA % Rank
US
87.97% 53.67% 104.41% 74.87%
Non US
11.83% 0.00% 45.40% 20.94%

WDNA - Expenses

Operational Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.45% 0.08% 3.13% 81.96%
Management Fee 0.45% 0.00% 1.25% 14.75%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

WDNA Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% 1.37%

WDNA - Distributions

Dividend Yield Analysis

WDNA Category Low Category High WDNA % Rank
Dividend Yield 0.85% 0.00% 2.44% 62.24%

Dividend Distribution Analysis

WDNA Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annually Quarterly Annually

Net Income Ratio Analysis

WDNA Category Low Category High WDNA % Rank
Net Income Ratio N/A -2.54% 1.92% 39.05%

Capital Gain Distribution Analysis

WDNA Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

WDNA - Fund Manager Analysis

Managers

Marlene Walker-Smith


Start Date

Tenure

Tenure Rank

Jun 01, 2021

1.0

1.0%

Marlene is head of equity index portfolio management. She leads the team of equity index portfolio managers managing US and non-US equity index portfolios and is responsible for the refinement and implementation of the entire equity index portfolio management process. Previously, Marlene served as a senior portfolio manager within the equity index team and prior to joining the equity index team was an equity trader for the firm. Prior to joining the firm in 1995, Marlene was a trader for Banc One Investment Advisors Corporation and a brokerage services manager for Mid Atlantic Capital Corporation. Marlene has been in the investment industry since 1990. Marlene earned an MBA in finance from the University of Pittsburgh and a BA in history and Russian from Washington & Jefferson College.

Todd Frysinger


Start Date

Tenure

Tenure Rank

Jun 30, 2021

0.92

0.9%

Mr. Frysinger is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2007.

Vlasta Sheremeta


Start Date

Tenure

Tenure Rank

Jun 30, 2021

0.92

0.9%

Ms. Sheremeta is a vice president and senior portfolio manager at Mellon. She has been employed by Mellon or a predecessor company since 2011.

David France


Start Date

Tenure

Tenure Rank

Jun 30, 2021

0.92

0.9%

Mr. France is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2009.

Michael Stoll


Start Date

Tenure

Tenure Rank

Jun 30, 2021

0.92

0.9%

Mr. Stoll is a vice president and senior portfolio manager at Mellon. He has been employed by Mellon or a predecessor company since 2005.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12